Figures & data
Table I. Patient characteristics.
Figure 1. Survival curves: Bold and thin lines indicate progression-free and overall survival, respectively. The median survival time and 1-year survival rate were 14.2 months and 64.5%, respectively, while the median progression-free survival time and 6-month progression-free survival rate were 4.0 months and 22.6%, respectively.
![Figure 1. Survival curves: Bold and thin lines indicate progression-free and overall survival, respectively. The median survival time and 1-year survival rate were 14.2 months and 64.5%, respectively, while the median progression-free survival time and 6-month progression-free survival rate were 4.0 months and 22.6%, respectively.](/cms/asset/251934df-24aa-49a5-9815-c29069916908/ionc_a_648342_f0001_b.gif)
Table II. Adverse events in the 31 patients with 101 courses.